Why SGLT2 inhibitors should be used in Heart Failure – Live Panel Discussion

In case you missed the cardiologist expert live panel discussion between CSANZ members (listed below) and Prof Meg Jardine, nephrologist.

• A/Prof John Amerena, Director of the Geelong Cardiology Research Unit
  Department of Epidemiology and Preventative Medicine at Monash University.
• Prof Meg Jardine, Professor and Director, NHMRC Clinical Trials Centre, Faculty of Medicine and Health(FMH) Senior Staff Specialist, Concord Repatriation General Hospital
• Prof Andrew Coats, AO, Director of the Monash Warwick Alliance and Academic Vice-President, Monash and Warwick Universities.
• Prof David Kaye, NHMRC Senior Principal Research Fellow, Director of the Department of Cardiology at The Alfred Hospital, and Head of the Heart Failure Research group at the Baker Institute.

Follow this link to the Free On Demand version on how SGLT2 inhibitors can provide beneficial effects in people with heart failure.

(Registration is required to access)